SUPPLY AGREEMENTSupply Agreement • May 9th, 2023 • Seres Therapeutics, Inc. • Pharmaceutical preparations
THIS SUPPLY AGREEMENT (the “Agreement”), effective as of March 13, 2023 (the “Effective Date”), is made and entered into by and between Seres Therapeutics, Inc., a corporation organized and existing under the laws of Delaware, having its principal place of business at 200 Sidney Street, Cambridge MA 02139, USA (“Seres”); and Nestlé Enterprises S.A., a stock corporation with its registered office located at Rue Entre-deux-Villes 12, 1800 Vevey, Switzerland (“NESA”). Seres and NESA may be referred to herein individually as a “Party” or collectively as the “Parties.”
